Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVLA | NUVB | RXRX | ||
| Company | Palvella Therapeutics Inc | Nuvation Bio Inc | Recursion Pharmaceuticals Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 115.26 | 4.75 | 3.03 | ||
| High | 117.61 | 4.80 | 3.14 | ||
| Low | 114.04 | 4.63 | 2.91 | ||
| Latest | 117.59 | 4.69 | 2.97 | ||
| Change | +3.60 | -0.03 | -0.04 | ||
| % Change | +3.16% | -0.64% | -1.33% | ||
| Volume | 126,700 | 2,719,600 | 29,619,799 | ||
| 20-Day Average Volume | 222,590 | 4,727,230 | 14,685,130 | ||
| Previous Close | 113.99 | 4.72 | 3.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 120.21 | 4.61 | 3.18 | ||
| 20-Day Raw Stochastic | 51.86% | 56.36% | 24.39% | ||
| 20-Day Relative Strength | 48.52 | 49.68 | 41.93 | ||
| Weighted Alpha | +171.42 | +52.77 | -41.95 | ||
| Today's Opinion | 40% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 40% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 80% Buy | 40% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.94% since 05/18/26 | +11.40% since 05/18/26 | +2.77% since 05/18/26 | ||
| Low | 101.29 on 05/19/26 | 4.07 on 05/19/26 | 2.77 on 05/19/26 | ||
| High | 117.61 on 05/26/26 | 4.89 on 05/22/26 | 3.17 on 05/22/26 | ||
| 1-Month | |||||
| %Chg | -4.85% since 04/24/26 | -4.09% since 04/24/26 | -15.38% since 04/24/26 | ||
| Low | 101.29 on 05/19/26 | 4.07 on 05/19/26 | 2.77 on 05/19/26 | ||
| High | 132.72 on 04/28/26 | 5.17 on 05/06/26 | 3.59 on 04/30/26 | ||
| 3-Month | |||||
| %Chg | -20.73% since 02/26/26 | -19.14% since 02/26/26 | -21.22% since 02/26/26 | ||
| Low | 101.29 on 05/19/26 | 4.05 on 03/30/26 | 2.77 on 05/19/26 | ||
| High | 146.60 on 02/27/26 | 5.92 on 02/27/26 | 3.90 on 04/16/26 | ||
| 6-Month | |||||
| %Chg | +17.60% since 11/26/25 | -41.45% since 11/26/25 | -32.65% since 11/26/25 | ||
| Low | 72.22 on 01/30/26 | 4.05 on 03/30/26 | 2.77 on 05/19/26 | ||
| High | 151.18 on 02/26/26 | 9.75 on 12/22/25 | 5.24 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,634,959 | 1,643,513 | 1,595,014 | ||
| Shares Outstanding, K | 14,343 | 348,202 | 529,905 | ||
| Annual Sales | 0 | 62,900,000 | 74,680,000 | ||
| Annual Net Income | -41,720,000 | -204,630,000 | -644,760,000 | ||
| Last Quarter Sales | 0 | 83,230,000 | 6,470,000 | ||
| Last Quarter Net Income | -15,770,000 | 5,400,000 | -117,500,000 | ||
| 60-Month Beta | -0.13 | 1.51 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.20 on 05/07/26 | 0.01 on 05/04/26 | -0.22 on 05/06/26 | ||
| Earnings Date | 08/13/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||